Carlton Evans is a
-Professor of Global Health at Imperial College London, UK;
-Honorary Consultant Physician specialising in infectious diseases at Imperial College Healthcare NHS Trust, UK;
-Professor of Research at Universidad Peruana Cayetano Heredia, Peru.
Leading a multi-disciplinary research team IFHAD: Innovation For Health And Development (www.ifhad.org).
Research is focused on developing and evaluating novel, equitable, practical strategies for tackling poverty and preventing associated tuberculosis in resource-constrained settings. See publications: https://goo.gl/CUYV9G.
Setting. Most of this research takes place in Peru, with collaborative research sites in several other countries.
Impacts include strengthening global policy and practice in tuberculosis:
-integration with psycho-socioeconomic interventions.
Capacity building involves mentoring and partnering with a dynamic research team including interns, PhD and Masters students in an international training network.
Collaborations in addition to the above list include:
-The Peruvian Ministry of Health;
-Asociacion Benefica PRISMA, Peru;
-Johns Hopkins University Bloomberg School of Public Health, USA;
-Tulane University, USA;
-The London School of Hygiene and Tropical Medicine, UK; Tulane
and is coordinated with Imperial College London, UK.
Funding is gratefully acknowledged from multiple sponsors including:
-The Wellcome Trust;
-The Joint Global Health Trials consortium (MRC, DFID, & Wellcome Trust);
-Imperial College National Institutes of Health Research Biomedical Research Centre;
-The Foundation for Innovative New Diagnostics (FIND);
-The Sir Halley Stewart Trust;
-The World Health Organization;
-The World Bank;
-The STOP TB partnership’s TB REACH initiative funded by the Government of Canada and;
-The Bill & Melinda Gates Foundation; and
-The charity fund IFHAD: Innovation For Health And Development.
Please send an email enquiry for further information or if you are interested in working with or supporting IFHAD.
et al., 2020, The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis., Lancet, Vol:395, Pages:973-984
Evans C, Please see attached file THIS LISTS ALL AUTHORS, COUGH DYNAMICS IN ADULTS RECEIVING TUBERCULOSIS TREATMENT, Plos One, ISSN:1932-6203
et al., Assessment of the feasibility and acceptability of using water pasteurization indicators to increase access to safe drinking water in the Peruvian Amazon, American Journal of Tropical Medicine and Hygiene, ISSN:0002-9637
et al., 2020, MDR/XDR-TB colour test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia., International Journal of Infectious Diseases, Vol:90, ISSN:1201-9712, Pages:213-218
Datta S, Evans CA, 2019, Healthy survival after tuberculosis, Lancet Infectious Diseases, Vol:19, ISSN:1473-3099, Pages:1045-1047